Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |
mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |